Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01737060
Other study ID # RTSA s422
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2013
Est. completion date September 1, 2022

Study information

Verified date October 2022
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the assumption that reversed shoulder prosthetic replacement will give a better functional outcome compared to open reduction and internal fixation with an angular stable plate in displaced proximal humeral fractures. Short name: The DelPhi trial.


Description:

Reversed total shoulder artroplasty (RTSA) equals Delta Xtend reversed total shoulder prosthesis. Angular stable plate means Proximal humerus plate (Philos)


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date September 1, 2022
Est. primary completion date August 1, 2017
Accepts healthy volunteers No
Gender All
Age group 65 Years to 85 Years
Eligibility Inclusion Criteria: Patient admitted in hospital with a displaced three- or four part proximal humerus fracture of OTA / AO group 11-B2 or 11-C2 (displaced fracture of extra-articular or articular, bifocal type). The subgroups -.1, -.2 and -.3 will be included for both B2 and C2 groups, provided severe displacement: This is defined as a mal-position of at least 45º of angular deviation in valgus or 30º in varus in true frontal projection, regardless of whether the fracture is impacted or not, or less than 50% contact between humeral head and the metaphyseal part of the shaft. The greater or lesser tubercle displaced at least 10 mm. Exclusion Criteria: Patient younger than 65 years or older than 85 years, previous history of injury or illness of the injured shoulder, injuries of other parts of the humerus or the contra-lateral upper extremity, alcohol- or drug abuse, dementia, neurological diseases, or severe cardiovascular or lung diseases that would contraindicate surgery. Patients have to understand the Norwegian language and be compliant to rehabilitation and follow-ups.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Reverse total shoulder arthroplasty


Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (7)

Lead Sponsor Collaborator
Oslo University Hospital Diakonhjemmet Hospital, Helse Forde, Sykehuset Asker og Baerum, Sykehuset i Vestfold HF, Sykehuset Ostfold, Sykehuset Telemark

Country where clinical trial is conducted

Norway, 

References & Publications (2)

Fjalestad T, Iversen P, Hole MØ, Smedsrud M, Madsen JE. Clinical investigation for displaced proximal humeral fractures in the elderly: a randomized study of two surgical treatments: reverse total prosthetic replacement versus angular stable plate Philos — View Citation

Fraser AN, Bjørdal J, Wagle TM, Karlberg AC, Lien OA, Eilertsen L, Mader K, Apold H, Larsen LB, Madsen JE, Fjalestad T. Reverse Shoulder Arthroplasty Is Superior to Plate Fixation at 2 Years for Displaced Proximal Humeral Fractures in the Elderly: A Multi — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other 15D Quality of Life score Follow-up will be at 3-6-12 months and 2-5 years. 5 years
Other Health Economics Follow-up will be at 3-6-12 months and 2-5 years. 5 years
Primary Constant Shoulder Score Follow-up will be at 3-6-12 months and 2-5 years. 5 years
Secondary Oxford Shoulder score Follow-up will be at 3-6-12 months and 2-5 years. 5 years